why choose us

First received: September 19, 2023

Clinical Trial: IC-8 Apthera IOL New Enrollment Post Approval Study

Study Status: Completed

Recruit Status: RECRUITING

Condition: Cataract

Study Type: OBSERVATIONAL


Official Title: IC-8 Apthera IOL New Enrollment Post Approval Study

Brief Summary: The purpose of this study is to verify the post-market safety of the IC-8 Apthera IOL after the treatment of posterior capsular opacification (PCO), an expected complication related to IC-8 Apthera IOL implantation.

Read more